These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 54713)

  • 1. Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).
    Lapes MJ; Vivacqua RJ; Antoniades K
    Lancet; 1976 Jan; 1(7952):198. PubMed ID: 54713
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
    Li FP; Willard DR; Goodman R; Vawter G
    Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of primary B-cell origin lymphoma of the stomach seen during diphenylhydantoin therapy (author's transl)].
    Matoba K; Katsumata T; Kakei M; Kuwata H; Nakazawa H; Saigeni K; Okabe H; Chin S; Maekawa K; Katsuoka K; Oh-Ida M; Atari H
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1797-802. PubMed ID: 6976466
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenytoin-induced pseudolymphoma syndrome: an immunologic study.
    Charlesworth EN
    Arch Dermatol; 1977 Apr; 113(4):477-80. PubMed ID: 848977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 6. A pseudolymphomatous reaction in soft tissue associated with phenytoin sodium.
    Wilden JN; Scott CA
    J Clin Pathol; 1978 Aug; 31(8):761-4. PubMed ID: 690240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macrocytic anemia due to folic acid deficiency and non-Hodgkin's lymphoma associated with prolonged diphenylhydantoin ingestion].
    Pereira A; Cervantes F; Rozman C
    Med Clin (Barc); 1985 Oct; 85(12):503-5. PubMed ID: 4079508
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudolymphoma induced by diphenylhydantoin.
    Gams RA
    J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632
    [No Abstract]   [Full Text] [Related]  

  • 9. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual dual hypersensitivity reaction induced by diphenylhydantoin.
    Sisca TS
    Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436
    [No Abstract]   [Full Text] [Related]  

  • 11. Pure red cell aplasia, toxic dermatitis and lymphadenopathy in a patient taking diphenylhydantoin.
    Huijgens PC; Thijs LG; den Ottolander GJ
    Acta Haematol; 1978; 59(1):31-6. PubMed ID: 146391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudolymphoma induced by diphenylhydantoin.
    Choovivathanavanich P; Wallace EM; Scaglione PR
    J Pediatr; 1970 Apr; 76(4):621-3. PubMed ID: 5420803
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
    Isobe T; Tomita M; Matsumoto J; Itoh T; Fujita T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):1-5. PubMed ID: 6858559
    [No Abstract]   [Full Text] [Related]  

  • 14. Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin.
    Tsung SH; Lin JI
    Ann Clin Lab Sci; 1981; 11(6):542-5. PubMed ID: 6976773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lymphadenopathy in phenytoin treatment].
    Marg E; Köpke E; Schillat I
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):430-6. PubMed ID: 100800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphadenopathy associated with diphenylhydantoin therapy.
    Abratt RP; Sealy R; Uys CJ; Lawson R
    Clin Oncol; 1982 Dec; 8(4):351-6. PubMed ID: 7168928
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Diphenylhydantoin effects in hypocalcemia.
    Trabulus J; Gulsrud PO; Chopra IJ
    Ann Intern Med; 1976 Jun; 84(6):709-10. PubMed ID: 937886
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolated malignant lymphoma of the jejunum and long-term diphenylhydantoin therapy.
    Rubinstein I; Langevitz P; Shibi G
    Oncology; 1985; 42(2):104-6. PubMed ID: 3887259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic problems in hydantoin immunopathy. Review of the literature and description of 3 cases].
    Amadori G; Fiore D
    Minerva Med; 1984 Nov; 75(42):2503-19. PubMed ID: 6392934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.